• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Terbinafine shows dose-dependency in tinea capitis

Article

New Orleans - Dose rather than duration of therapy appears to be the important factor for achieving favorable cure rates using oral terbinafine (Lamisil) for the treatment of tinea capitis, Sheila Fallon Friedlander, M.D., said at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content
Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

Article
ReV Up Your Vitiligo Treatment Strategies

ReV Up Your Vitiligo Treatment Strategies

Podcast
Reviewing the Rosacea Pipeline: A Look at the Last 10 Years

Reviewing the Rosacea Pipeline: A Look at the Last 10 Years

Article
Is Your Texting as Caring as Your Bedside Manner?

Is Your Texting as Caring as Your Bedside Manner?

Article
© 2024 MJH Life Sciences

All rights reserved.